1. Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.
- Author
-
Damasceno NP, Horowitz SA, and Damasceno EF
- Subjects
- Aged, 80 and over, Amikacin therapeutic use, Anti-Bacterial Agents therapeutic use, Endophthalmitis diagnosis, Endophthalmitis drug therapy, Eye Infections, Bacterial diagnosis, Eye Infections, Bacterial drug therapy, Gram-Positive Bacterial Infections diagnosis, Gram-Positive Bacterial Infections drug therapy, Humans, Intravitreal Injections, Male, Vascular Endothelial Growth Factor A antagonists & inhibitors, Vitreous Body microbiology, Wet Macular Degeneration drug therapy, Angiogenesis Inhibitors administration & dosage, Endophthalmitis microbiology, Eye Infections, Bacterial microbiology, Gram-Positive Bacterial Infections microbiology, Leuconostoc isolation & purification, Postoperative Complications, Ranibizumab administration & dosage
- Abstract
Purpose: The authors report a case of endophthalmitis after intravitreal injection of ranibizumab., Methods: After searching for extensive laboratory tests to isolate the etiologic agent Results: The agent was determined as Leuconostoc mesenteroides, gram-positive cocci, vancomycin resistant., Discussion: Considerations regarding this bacterium were done by calling attention to its rarity, difficulty of isolation, and action on secondary comorbidities as opportunistic pathogen.
- Published
- 2016
- Full Text
- View/download PDF